Medications for Hypophosphatasia (HPP)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hypophosphatasia (HPP).
Found 1 Approved Drug for Hypophosphatasia (HPP)
Strensiq
Generic Name
Asfotase
Strensiq
Generic Name
Asfotase
Form: Solution
Method of administration: Subcutaneous
FDA approval date: October 23, 2015
Classification: Tissue-nonspecific Alkaline Phosphatase
STRENSIQ ® is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). STRENSIQ is a tissue nonspecific alkaline phosphatase indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances